The Mexico Summit on Health Research 2004BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7488.421 (Published 17 February 2005) Cite this as: BMJ 2005;330:421
Mexico agenda was informed by wide consultation
- Tikki Pang, director, research policy and cooperation ()
EDITOR—Three issues raised by Abbasi in his editorial on the recently concluded Ministerial Summit on Health Research in Mexico deserve comment.1
Firstly, Abbasi laments the lack of translatable actions but did not mention additional action items. These were related to a call to donors for more substantive support for health systems research, a call to governments to allocate a certain percentage of national health expenditures to research, and a call to work more closely with countries to use evidence better in health decision making.
Secondly, he was critical of the Mexico agenda, which he states was “drafted largely by representatives of the rich.” It should be pointed out that the development of the agenda was informed by wide ranging consultations and meetings in all WHO regions which involved researchers, policy makers, and non-governmental organisations. Ultimately, the agenda will be discussed at the governing bodies of the WHO where all member states will have a chance to comment and take ownership.
Thirdly, to state that “everything under the sun” was tied to the millennium development goals is not correct. The agenda clearly acknowledges the importance of other communicable diseases, non-communicable diseases, sexual and reproductive health, injuries, violence, and mental ill health. Together with its member states the WHO is committed to translating the agenda into measurable actions.
Competing interests None declared.